Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2005-09-27
2005-09-27
Stockton, Laura L. (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C548S340100
Reexamination Certificate
active
06949577
ABSTRACT:
The present invention provides compounds of formula (I)as well as the use of such compounds in pharmaceutical compositions and methods of treatment.The compounds described herein represent a class of TAFIa inhibitors suitable for use in treating conditions such as thrombosis, atherosclerosis, adhesions, dermal scarring, cancer, fibrotic conditions, inflammatory diseases and those conditions which benefit from maintaining or enhancing bradykinin levels in the body.
REFERENCES:
patent: 4528397 (1985-07-01), Shibamoto et al.
patent: 4743614 (1988-05-01), Terano et al.
Allerton Charlotte Moira Norfor
Blagg Julian
Bunnage Mark Edward
Steele John
Ashbrook Charles
Kasten Daniel S.
Pfizer Inc.
Stockton Laura L.
LandOfFree
Pharmaceuticals does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pharmaceuticals, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceuticals will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3440284